BioCryst Pharmaceuticals
BCRX
#4675
Rank
$2.28 B
Marketcap
$8.99
Share price
0.45%
Change (1 day)
-10.99%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of March 2026 : $0.81 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is $0.81 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$0.43 B-45.73%
2024-12-31$0.80 B-1.99%
2023-12-31$0.82 B11.29%
2022-12-31$0.74 B24.98%
2021-12-31$0.59 B112.25%
2020-12-31$0.27 B230.17%
2019-12-31$84.65 M36.93%
2018-12-31$61.82 M12.98%
2017-12-31$54.72 M1.86%
2016-12-31$53.72 M78.02%
2015-12-31$30.17 M0.6%
2014-12-31$30 M0%
2013-12-31$30 M0%
2012-12-31$30 M0%
2011-12-31$30 M
2000-12-31$0 M
1997-12-31$0.1 M-66.67%
1996-12-31$0.3 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
$22.17 B 2,611.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$25.23 B 2,986.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$1.03 B 26.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$0.68 B-15.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$0.29 B-63.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$1.9 M-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$1.5 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$9.38 M-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B-18.91%๐Ÿ‡บ๐Ÿ‡ธ USA